BioCatalyst

Afimkibart — catalyst calendar

2 verified catalyst event(s) referencing Afimkibart, each linked to its official source. Verified as of 2026-11-04.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-31
in 2mo
ESTIMATED
 READOUT
Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Di
Phase 2 · Crohns Disease
 Hoffmann-La Roche Afimkibart ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
2027-01-30
in 3mo
ESTIMATED
 READOUT
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121
Phase 3 · Moderately to Severely Active Ulcerative Colitis
 Hoffmann-La Roche Afimkibart ClinicalTrials.gov ↗
✓ Source-checked 2026-11-04
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.